DOPA decarboxylase levels in the cerebrospinal fluid as a diagnostic marker of Lewy body disorders

Nature Medicine 2026

View at publisher

DOI: 10.1038/s41591-026-04243-7

Cited by: 0

References: 4

Fields of Study & Subjects

Parkinson's Disease Mechanisms and Treatments Dementia and Cognitive Impairment Research Neurological diseases and metabolism

References 4